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ABSTRACT: An ultra scale-down method is described to determine
the response of cells to recovery by dead-end (batch) centrifugation
under commercially deﬁned manufacturing conditions. The key
variables studied are the cell suspension hold time prior to
centrifugation, the relative centrifugal force (RCF), time of
centrifugation, cell pellet resuspension velocities, and number of
resuspension passes. The cell critical quality attributes studied are the
cell membrane integrityandthe presence of selected surface markers.
Greater holdtimes and higher RCF valuesfor longerspintimes all led
totheincreasedlossofcellmembraneintegrity.However,thislosswas
found to occur during intense cell resuspension rather than the
preceding centrifugation stage. Controlled resuspension at low stress
conditions below a possible critical stress point led to essentially
complete cell recovery even at conditions of extreme centrifugation
(e.g.,RCFof10000gfor30mins)andlong(~2h)holdingtimesbefore
centrifugation. The susceptibility to cell loss during resuspension
under conditions of high stress depended on cell type and the age of
cells before centrifugation and the level of matrix crosslinking within
thecellpelletasdeterminedbythepresenceofdetachmentenzymesor
p o s s i b l yt h en a t u r eo ft h er e s u s p e n s i o nm e d i u m .C h a n g e si nc e l l
surface markers were signiﬁcant in some cases but to a lower extent
than loss of cell membrane integrity.
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Introduction
The capacity to bring new whole cell therapies and regenerative
medicinestoawiderangeofpatientswillultimatelyrestontheability
toprocesslargenumbersofcellseitherbyscaleuporscaleoutroutes
to manufacture (Brandenberger, 2011; Seth et al., 2006; Want et al.,
2012; Zoro et al., 2008). Within a bioprocessing sequence the cell
product will undergo a series of stages that will involve exposure to
stress which may lead to adverse effects on cell quality, for example,
membrane leakage (Barbee, 2005; Dhondalay et al., 2014; Ma et al.,
2002; McCoy et al., 2009; McCoy et al., 2010), physiological and
metabolic changes (Al-Rubeai et al., 1995), lysis, apoptosis or
necrosis (Mollet et al., 2007; Tanzeglock et al., 2009). One
requirement of cell bioprocessing is the need to recover the cells,
without damage, from solution, for example, to remove growth or
storage medium or to concentrate cells for administration in low
volumes or for mixing with a scaffold agent in tissue preparation.
The most common method for separation, both during
expansion seed trains and ﬁnal product harvest stages, is to pellet
the cells by dead-end (batch) centrifugation and then to resuspend
the cells into a speciﬁed medium. While this method is not
amenable to fully-enclosed operation (e.g., use of sterile hoods is
required for transfer stages) it does provide the basis for an easily
accessible process which may be used over a wide range of the
relatively small scales relevant to the manufacture of cells for
therapy (Pattasseril et al., 2013). It also beneﬁts from use of low
hold up volumes and the option to deliver cells at a wide range of
concentrationsincluding cellpastes. Alternativeseparationsystems
which allow fully-enclosed operation will be discussed later.
Bench-scale processes for cell preparation generally use batch
dead-end centrifugation operating at a low relative centrifugal force
for short times for cell recovery, for example, 500–1000xg for 3–
6mins (Dar et al., 2002; Pollock et al., 2006). It is expected that the
stress onthe cellsmay be reduced by the use ofsuch conditions but
a sizeable fraction of the population may be lost by their failure to
pellet (Katkov and Mazur, 1999), that is, care is required to remove
the supernatant from the loose sediment without resuspending the
cells. A typical manufacturing process might employ a similar
strategy (Lapinskas, 2010) with multiple centrifugation and
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contaminants (e.g., cell metabolites, serum based proteins, and
remaining growth factors).
High levels ofcompaction are of interest where greaterextents of
soluble contaminant removal are required to reduce number of
wash stages and hence processing time and also where high cell
densities (~100 10
6cells/mL) are required to mix with a matrix
scaffold for tissue formation (Dar et al., 2002). The use of high
relative centrifugal forces will lead to the formation of compacted
pellets; however the resuspension of these may expose cells to high
levels of mechanical agitation, leading to a loss in cell integrity
(Katkov and Mazur, 1998). For example, attempts to quantify cell
recovery during centrifugation indicated 20 þ/  13% loss of cells
whichwasnotaccountableascellslost inthesupernatantorascells
attached to surfaces (Zoro et al., 2009).
In this study we seek to evaluate dead-end centrifugation as a
means of cell recovery and concentration and the effects upon cell
quality as a result of the relative centrifugal force and time of
centrifugation used. The cell lines studied are candidates for a
cancer vaccine therapy (Eaton et al., 2002; Ward et al., 2008) where
the processing challenges are as for cell therapy preparation in
general. A selection of operating variables as might determine the
performance of dead-end centrifugation is studied using an ultra
scale-down approach. This is to allow the exposure of small
quantities of cells to various combinations of deﬁned operating
conditionsoverrangesbothwithinandoutsidethosenormallyused
at the full scale and in this way to gain an understanding of
processing effects which may lead to cell loss, and conversely
operating regions where acceptable performance might be gained.
Materials and Methods
Cell Preparation
Twocelllinecandidatesforacancer vaccinetherapy,OnyCap23and
P4E6 (Onyvax Ltd, London, UK, passage number range 51–63)
were culturedto70–80% conﬂuency (T175 ﬂasks, Greiner Bio-One,
Germany) in complete growth medium (CGM; keratinocyte serum-
free medium with epidermal growth factor at a ﬁnal concentration
of 5ng/mL, both Invitrogen, Paisley, UK and 2% [v/v] fetal calf
serum, FCS; Thermo Fisher Scientiﬁc, Northumberland, UK); see
(Acosta-Martinez et al., 2010) for details. OnyCap23 was clonally
derived using the PNT2-C2 prostate cell line transformed by SV40
(Berthonetal.,1995)andP4E6wasderivedfromprimarycultureof
an early prostate cancer biopsy (Maitland et al., 2001). Cell harvest
wasbydecantationtoremovespentgrowthmedium,cellincubation
in 5mLTrypLE Select solutionper ﬂask (Invitrogen) for 6–8min at
37 C, quenching in 5mL CGM, centrifugation at 500g, 3min, 21 C
(Heraeus Multifuge X3R, Thermo Fisher Scientiﬁc, Basingstoke,
UK),andcellresuspensionin~10mLCGMtoyieldasuspensionof
2 10
6cells/mL at 21 C. The cells were used within 5min for
centrifugation studies. Variables in cell preparation included:
resuspension to a cell concentration of 1 10
6cells/mL by dilution
in CGM; replacement of CGM with HBSS free of Ca
2þ and Mg
2þ
(Hank’s balanced salt solution; Sigma–Aldrich, Ayrshire, UK) for
cell resuspension; and controlled holds at 21 C for 120min of the
cells before use for centrifugation studies.
Centrifugation Studies
The extent of cell concentration achieved as a result of dead-end
centrifugation was studied using 0.5mL aliquots of cell suspension
exposed to RCF of 200 to 20000xg for 1–30min at 21 C( V o l u P a c
tubes,Sartorius,Surrey,UKin5430R,Eppendorf,Cambridge,UK).
The effect of recovery by centrifugation on the properties of the
resultant resuspended cells was studied for a ﬁxed method of cell
resuspension (see Fig. 1 for sequence of operations making up this
procedure). Centrifugation of 1mL aliquots of cell suspension was
byexposure to RCFof250 to 20000xg for 3–30min at 21 C (5430R,
Eppendorf). The manual resuspensionmethodwasby removal and
retention of the cell supernatant, tapping (~2 to 3 times) of the
centrifuge tube until the pellet is visibly detached from the tube
sides, use of the retained supernatant to resuspend the cell pellet
using a 1.0 þ/ 2.5% mm id tip pipette (Gilson Scientiﬁc Ltd,
Luton, UK) located ~5mm above the sediment surface operated in
injection/suction mode timed separately at ~2 passes per second
for 10 passes (mean velocity at tip 2.5m/s þ/  10%). Additional
passes were used (<10) in the few cases where visible clumps
remained. An alternative method of resuspension was by means of
an electronic multichannel pipette (EDP
1
3, Rainin, CA) ﬁtted with
1.0 þ/  2.5% mm id tips and located as above and programmed,
based on initial observations of cell dispersion, to withdraw and
redispense over a period of ~2min for 110 times, 500mLo f
suspensionat500mL/s(0.65m/s).Whereenzymatic treatmentwas
Figure 1. Sequence of processing stages used in centrifugation and resuspension studies (not to scale)—see text for detail. Stage 5 shows tube contents with suspending
liquor withdrawn into pipette tip and about to be reinjected into suspension. For manual resuspension this occurs in a few (ca 10) high ﬂow velocity cycles. For automated
resuspension this occurs in many (ca 20–100) low velocity cycles.
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retained for later resuspension. TrypLE Select, 500mL, was pre-
warmed to 37 C and added to cover a cell pellet and incubated at
21 C for 15mins. For manual resuspension as above, the TrypLE
Select was removed and mixed with the original supernatant, the
pellet loosened by tapping and the TrypLE Select/supernatant mix
used for resuspension. For electronic resuspension as above, the
retained supernatant was added tothe TrypLE Select to provide the
resuspension medium.
The effect of the number of resuspension passes was studied
using cell pellets prepared in multiwell plates (96 deepwell 2mL
round-bottomed, circular cross-section wells, Starlab Ltd., Milton
Keynes, UK) ﬁlled with 0.7mL/well of a 2 10
6cells/mL
suspension and centrifuged at either 1500xg or 2500xg for 5min
(Heraeus Multifuge). Resuspension was by controlled aspiration
cycles using an automated platform (Freedom Evo
1
75;Tecan,
Männedorf, Switzerland) with pipette tips of 0.76mm id, located
4.57mm(i.e.,6 id)abovethepelletsurfaceandadispensing ﬂow
rate of either 600mL/s (1.3m/s) or 900mL/s (2.0m/s).
Analysis of Cell Suspension
Cells were counted and analysed for number, integrity and size (Vi-
CELL XR
TM automated analyser Beckman Coulter, High Wycombe,
UK). The system utilizes the trypan blue exclusion method on a
basis of image capture (50 images) and their subsequent analysis.
Sizeanalysisisachievedbymeasurementoftheequivalentspherical
diameter of all imaged cells.
Samples of processed cells were analysed for surface marker
expressionwithin 7 days of freezing. Sampleswere thawed (~3min,
37 C),centrifugedandthecellsresuspendedinDPBS,0.1%w/vBSA
and0.01%w/vNaN3to 5 10
6totalcells/mL.Aliquots,40mL,were
washed twice with 100mL/well of DPBS-BSA-NaN3 solution,
incubated(4 C,20min)withselectedmouseanti-humanantibodies,
CD9,CD81,andCD147(1:40dilution),CD44andMHC1(1:300),and
CD59 (1:20) (BD BioSciences, Oxford, UK). IgG1 (clone MOPC-21)
and IgG2a (clone G155–178) monoclonal isotypes were used as
controls. The labeled cells were washed twice with 100mL DPBS-
BSA-NaN3 and incubated (4 C, 20min) in the dark with a 1:20
dilutionofgoatanti-mouseantibody(BDBioSciences).Theresultant
cellswerewashedtwice(100mLDPBS-BSA-NaN3)an dr es us pe nd ed
in200mLofF A CSﬂowandanalyzed(EpicsXLMCLFlowCytometer,
BeckmanCoultercalibratedusingQIFIKITbeads,DakoLtd.UK,Ely,
UK coated with different, but well-deﬁned, quantities of the
respective mouse monoclonal antibodies to generate a calibration
curve for the processed cells labeled to saturation with primary
mouse monoclonal antibodies; a secondary ﬂuorescent polyclonal
goatanti-mouseimmunoglobulinisusedtotrackmousemonoclonal
antibody binding). Mean ﬂuorescence intensity (MFI) values were
analysed (WinMDI Software, FACS Core Facility, Scripps, CA) and
recorded as number of antigenic sites per cell specimen.
Design of Experiment (DoE) studies
Selected ranges of three operating variables, hold time of the cells
before centrifugation, centrifugation RCF and time, were studied
using a deﬁned DoEprotocol at low, mid, and highpoints using the
manual resuspension methods described above and analysis of the
cell membrane integrity and total cell count before and after
centrifugation and resuspension. All measurements of each run
werecarriedoutintriplicateandtheresultswereanalysedusingthe
DoE software (Design Expert v7, Stat-Ease, Minnaeapolis, MN)
Results
Cell Compaction Studies
Dead-endcentrifugationprocessesforcellpreparationgenerallyuse
a low RCF for short times yielding loosely compacted cell
suspensions. As discussed earlier, high levels of compaction are of
interest to reduce washing stages and forcell preparation for tissue
formation(Daret al., 2002). To set the boundariesfor the dead-end
centrifugation studies inthis investigationthe impact ofcentrifugal
forceandspintimeonthevolumeofsedimentforaﬁxednumberof
cellswasdetermined(Fig.2).The cellconcentrationsachievedfora
spin time of 3 or 30min increased up to values of RCF ~20000xg
with a ~30% increase compared to that achieved at ~500xg
(Fig. 2A). Similarly the concentrations achieved for a RCFof 250 or
2500xg increased up to spin times of 30min with a 20% increase
compared with centrifugation for 3min (Fig. 2B). The resultant
effectisuptoadoublingincellconcentrationbeingachievedforthe
most extreme centrifugation conditions studied as compared with
those conditions commonly used at bench scale. The same trends
were observed for both cell lines studied but with considerably
greater concentration being obtained for P4E6 as compared with
OnyCap23cells. Further analysis of the extents ofcellconcentration
(and hence cell sediment dewatering) achieved are presented inthe
Discussion section. For all centrifugation conditions studied in
Figure 2, complete cell removal from the suspension was recorded
by cell count analysis of the sample supernatant (data not shown).
Ultra Scale-Down Analysis of Centrifugation Conditions
Studies to evaluate the effect of centrifugation conditions on cell
quality were carried out for the full range of conditions used in
Figure2,thatis,RCFof250to20000xgfor3to30min.Inadditiona
third variable studied was the hold time of the cells after
detachment from the growth surfaceand before centrifugation,this
rangingfrom5to120min.Theformertimeisasmighttraditionally
beachievedatbenchscaleandthelatterismoretypicaloffull-scale
processing (e.g., Onyvax private communication for a process
involving theharvestofsixteen40layercellfactoriesyielding~20L
suspension per factory).
Three performance factors are used to characterize the effect
on the cells of the combinations of operating conditions used.
The retention of cell membrane integrity, V, of the resultant cell
suspension relevant to the original cells is given by V¼100
(Cout/Cin) where C is % of cells which are viable (in terms of the
membrane integrity remaining intact with respect to trypan
blue exclusion), and the subscripts “in” and “out” refer to before
and after combined operations of centrifugation and resus-
pension. The yield of total cell numbers, Y, is given by Y¼100
(Tout/Tin) where T is the total number of cells recorded, whether
viable or non-viable. The key summarized performance factor is
Delahaye et al.: Ultra Scale-Down Analysis of Human Cell Centrifugation 999
Biotechnology and Bioengineeringgiven by the % total recovery, REC, of cells with intact
membrane:
REC ¼ VY=100 ¼ 100 CoutTout ðÞ = CinTin ðÞ ð 1Þ
Theexperimentaldesignofexperimentsconstructionalong with
all the results achieved are summarized in Table Iwith “l,”“ m,” and
“h”usedtorepresentthelow,midpoint,andhighendofrangesused
for the hold time before centrifugation, the RCF, and the spin time.
Controls carried out using gravity settling for a time equal to the
combined hold and spin times showed no signiﬁcant loss of cell
membrane integrity, yield or overall recovery of cells with an intact
membrane (results not shown here). Some observations from
Table Iinclude:(i) a good level ofreproducibility inthe three repeat
samples carried out at the medians of the ranges studied (mmm);
(ii) full recovery of intact cells at the mildest centrifugation
Figure 2. Cell concentration in a centrifuged pellet as a function of spin time and RCF for OnyCap23 (*, ~) and for P4E6 ( , D). The cell concentration values are calculated
from thesedimentvolumes derivedfrom knownnumbersofcellspresentedforcentrifugation.Trendsshownarewithrespectto(A)changingmaximumRCFforaconstantspintime
of 3min (~, D) or 30min (*,  ) and (B) changing spin time for constant maximum RCF of 250xg (~, D) or 2500xg (*,  ). Results are means þ/  sd of separate centrifugation
studies (n¼3); lines are best ﬁt by eye. Initial concentration used was 2 10
6cells/mL.
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freshlyharvestedcells(lll);(iii)thelowestvaluesofcellrecoveryare
for extreme centrifugation conditions (RCF ¼20000xg for 30min
spin time) for aged cells (hhh); (iv) greater cell losses for lower
concentration feed stocks; (v) a greater susceptibility to cell loss
when processing OnyCap23 as compared with P4E6; (vi) the effect
of hold time before centrifugation is to increase loss. For P4E6 cells
the main reason for lower levels of recovery of intact cells, REC,
appears to be due to loss of cell membrane integrity, V, rather than
loss of yield, Y, while for OnyCap23 low levels of loss are associated
withlossofcellqualitywhilehighlosslevelsareassociatedwithloss
of both cell membrane integrity and cell yield. This loss of yield is
attributed to cell fragmentation rather than adherence to the
surfaces of the centrifuge tube or pipette tip (studies using TrypLE
Select suspension for 10min to detach any remaining cells showed
no increase in yield- results not shown here).
Figures 3–5 give the visual representation of the output of the
DoE studies. Figure 3 presents a signiﬁcance evaluation alongside a
Paretto analysis and P values-of-signiﬁcance for all possible
combinations of operating variables. All combinations of the RCF,
spin time and hold time before centrifugation are studied to seek
evidencefor bothindividual andsynergisticeffectsoncellrecovery.
Fortherangesused,RCFandspintimeandtheproductoftheseare,
in all cases, the strongest determinants of performance. For P4E6
cells at both concentrations the effect of hold time (and
combinations involving hold time) are probably statistically
insigniﬁcant. However, for OnyCap23 cells at both concentrations
(Fig. 3B and D) the hold time and various combinations of hold
time, RCF, and spin time can also be considered to be signiﬁcant
determinants of performance. It is noted that the behaviour
exhibited for high concentration of OnyCap23 (Fig. 3B) is markedly
differenttothatfortheotherthreecasesstudied;thisisattributedto
an increased effect of hold time prior to cell concentration and will
be discussed later. In order to have a consistent approach to the
interpretation of the DoE studies all process variables and their
combinations were used in the development of correlations but the
emphasis for analysing the results of the correlations derived was
based on RCF and spin time and their combination.
The derived contour plots relating the two mainvariables of RCF
andspintimeareshownforthetwocelllinesinFigs.4and5andthe
effect of holding time is discussed in the respective legend. The
conﬁdenceofalltherelationsderivedrelatingRECandRCF,spintime
and hold time are high (in all cases P<0.03). For P4E6 small but
signiﬁcant increases in level of cell loss occur for greater extents of
RCFandspintimeused(Fig.4).Thelevelofcelllossincreasesslightly
when processing cell suspensions of greater age and of lower
concentration. In all cases there is an operating window where the
combinationofRCFandspintimeissuchthat 99%recoveryofcells
isachievedwhilestillachievingmodestlevelsofcellcompaction(e.g.,
RCF of 2500xg for 10min yielding ~600 10
6cells/mL—Fig. 2).
Table I. Operation and results of Design of Experiment studies to examine effects of relative centrifugal force (R), spin time (S), and hold time prior to
centrifugation (H).
P4E6, 2x10
6cells/mL, CGM OnyCap23, 1x10
6cells/mL, CGM
R S H Run Cin Tin Cout Tout VY R EC Run Cin Tin Cout Tout VY R EC
l l l 6 96 1.95 96 1.95 100 100 100 0 2 96 1.95 95 1.95 100 100 100 0
l l h 7 96 1.95 96 1.95 100 100 100 0 4 96 1.95 96 1.95 100 100 100 0
l h l 11 97 2.05 95 2.05 98 100 98 0 8 98 2.03 98 2.03 100 100 100 0
l h h 9 97 2.05 96 2.05 99 100 99 0 7 98 2.03 97 2.03 99 100 99 0
h l l 4 95 2.06 95 2.05 100 99 99 1 3 96 1.95 93 1.93 97 99 96 1
h l h 2 95 2.06 94 2.06 99 100 99 1 10 98 1.98 95 1.97 97 99 96 1
m m m 1 95 2.06 92 2.04 97 99 96 1 1 96 1.95 91 1.93 95 99 94 3
m m m 3 95 2.06 94 2.04 99 99 98 0 9 98 1.98 96 1.96 98 99 97 5
m m m 5 96 1.95 93 1.95 97 100 97 1 6 98 2.03 94 2.01 96 99 95 1
h h l 10 97 2.05 92 2.03 95 99 94 3 5 98 2.03 89 1.98 91 97 89 3
h h h 8 96 1.95 88 1.92 92 98 90 1 11 98 1.98 53 1.69 54 85 46 3
P4E6, 2x10
6cells/mL, CGM OnyCap23, 1x10
6cells/mL, CGM
R S H Run Cin Tin Cout Tout VY R EC Run Cin Tin Cout Tout VY R EC
l l l 6 96 1.03 96 1.03 100 100 100 0 9 97 1.01 97 1.01 100 100 100 0
l l h 11 96 0.99 96 0.99 100 100 100 0 5 96 0.98 94 0.95 98 97 95 7
l h l 2 94 0.95 94 0.95 100 100 100 0 8 96 0.98 96 0.98 100 100 100 0
l h h 5 96 1.03 95 1.03 99 100 99 1 10 97 1.01 92 0.95 95 94 89 2
h l l 3 94 0.95 93 0.95 99 100 99 1 6 96 0.98 93 0.97 97 99 96 2
h l h 8 96 1.03 96 1.03 100 100 100 0 3 98 1.04 92 1.04 94 100 94 3
m m m 9 96 0.99 92 0.99 96 100 96 1 4 98 1.04 90 0.82 92 79 72 3
m m m 10 96 0.99 93 0.98 97 99 96 2 7 96 0.98 86 0.80 90 82 73 6
m m m 1 94 0.95 92 0.94 98 99 97 1 11 97 1.01 84 0.83 87 82 71 4
h h l 4 94 0.95 87 0.95 93 100 93 1 1 98 1.04 85 0.91 87 88 76 3
h h h 7 96 1.03 86 1.02 90 99 89 2 2 98 1.04 67 0.67 68 64 44 5
Ranges used are, for h, m, l, R¼20000, 10125, 250xg (note for OnyCap23 1 10
6cells/mL R¼11350, 5800, 250xg), S¼30, 16.5, 3min, H¼120, 62.5, 5min. The results
arereportedintermsoftotalcellnumber,T 106/mL,cellmembraneintegrity,C%,retentionofcellmembraneintegrityV%,cellyieldY%,andrecoveryofintactcellsREC%
(seeequation1).Allexperimentswereforeachcentrifugationsamplemeasuredintriplicate.OnlymeanvaluesforT,C,andVpresentedwithoutliersremovedasdeﬁnedbydata
external to range þ/  1 sd. Values for REC are referred as mean þ/  sd (n¼3). See text for details of controls.
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6cells/mLareachievablewith
4–5% cell loss (RCF 10000xg for 30min) for all start concentrations
andholdtimesused.Asimilar recovery performanceisavailablefor
OnyCap23 cells (Fig. 5) but only for fresh cells processed at high
concentration (Fig. 4B). For cells previously held for 120min before
processing high recovery levels (REC>99%) with modest levels of
compactionarestillpossiblebutanyattempttoachievehighlevelsof
compactionresultsinveryhighlosses.Operationwitheitherfreshor
aged cells at lower cell concentrations results in signiﬁcant cell loss
even under mild centrifugation conditions although it should be
notedthat100%cellrecoverywasrecordedatthemildestconditions
of 250xg for 3min (Table I).
Figure 6 provides one further measure of the impact of
centrifugation on critical cell quality attributes, that is, the presence
of cell surface molecules. Even at extreme conditions of
centrifugation, that is, RCF of 20000xg, spin time of 30min, the
highlevelsofcellrecoveryobservedprocessingfreshcellsismatched
by a high level of recovery of a range of surface markers associated
withdifferentbiologicalfunctions(seeﬁgurelegendfordetails).Only
for the CD59, CD147, and the CD81 markers is there signiﬁcant and
consistentevidenceofloss(ordownregulation),albeittoarelatively
small (~10%) extent.Thelevels of loss are muchlower thanthe loss
of membrane integrity recorded for OnyCap23. In all other cases,
thereisnosigniﬁcantdifferenceinmarkerlevelexceptforCD9where
thereisbothupregulationforOnyCap23andlossordownregulation
for P4E6,but again only to a small (~10%)extent.As can beseen in
Figure 6 the changes in marker level are well below those deemed
unacceptable as described in the product release speciﬁcations.
However, even small changes as recorded here may be an indication
of anunacceptablechange of thecells if theyareto beused forother
therapeutic proposes. It should be noted that the marker levels were
for cells which had also been freeze—thawed as might occur in a
process preparation, for example, for cell therapy preparation in
phasebetweenprocessingandadministrationorforavaccinestorage
(McCoyet al., 2009,2010) and somay be affected bysmall extents of
lysis occurring during freeze thaw. Surface marker analysis of cells
beforefreezing(e.g.,usingmultiplexanalysistoensurerapidanalysis
of multiple markers) would be necessary if the effects of
centrifugation alone were to be studied but the relatively small
changes noted in Figure 6 indicate little change inthe centrifugation
step alone.
Image analysis of the total cell population of surface attached
cells as a result of centrifugation and resuspension show little
change in cell morphology (results not shown here). The size
distributions of various cell preparations in suspension were
analysedby image analysiswiththe size relatedtothe diameterofa
sphere with equivalent projected area. Sample size distributions for
P4E6 cells before centrifugation (Fig. 7) show a monomodal
distribution with some clumping. Centrifugation and resuspension
appears to just disrupt the clumps resulting in similar size
distributionsforthevariousconditionsstudiedrangingfromgentle
centrifugation (RCF¼250xg for 3min) of fresh cells to extreme
centrifugation (RCF¼20000xg for 30min) of aged cells. Similar
results are noted for OnyCap23 cells except for the appearance of a
bimodal distribution at extreme centrifugation conditions of aged
cells.OfnoteisthelargersizeofOnyCap23cellswithanaveragecell
volume 1.2 fold larger than P4E6.
Onemajorsourceofappliedshearstresswill beduringcellpellet
resuspension with repeated ﬂow through a pipette tip. To explore
the effects of shear stress, the resuspension is studied of sediments
prepared using extreme centrifugation conditions (RCF ¼20000xg
for 30min) of fresh (Fig. 8A) and of aged (Fig. 8B) cells. As before,
manual resuspension leads to small reduction in recovery of P4E6
cells and a high reduction in recovery of OnyCap23 cells. In both
casescellaging leads to agreaterloss.Achange incellenvironment
prior to centrifugation from the protein based cell growth medium
(CGM) to a HBSS buffer free of Ca
2þ and Mg
2þ results in
subsequent higher yields of recovered intact cells. Pre-treatment of
the cell pellet to enzymatically digest matrices which will have
formed between cells, and hence detach the cells, leads to no cell
loss even when using a high ﬂow velocity during cell resuspension.
Evidently it is the use of high velocity ﬂow stresses for the initial
detachment of the cells within the highly compacted pellet which
leads to loss ofintactcells.Once thecells aredetached and/orfreely
3—————————————————————————————————————————
Figure 3. Signiﬁcance study (top set of ﬁgures) and Paretto analyses (lower set of ﬁgures) of experimental variables studied on loss of intact cells (see Table I for ranges
studied)duetoexposuretovariouscombinationsofholdtimebeforecentrifugation(H),relativecentrifugalforce(R),andspintime(S).Forthesigniﬁcancestudiesplots,theinclined
line is indicative of locus of points where the operating variable or combination of operating variables has no signiﬁcant effect on cell recovery. The standardized effect is
proportional to the square of the effect of operating variable or combination on the resultant loss of intact cells. The corresponding half normal probability values indicate the
likelihood that the particular factor or interaction is going to inﬂuence that response. For the Paretto plots, the upper bonferroni limit indicates the operating variables or
combinations where the statistical conﬁdence of their impact is greater than that for the overall model ﬁt; the lower limit indicates operating variables or combination provide a
signiﬁcant contribution to the overall model ﬁt. The P values-of-signiﬁcance for each DOE-derived effect are as follows:
.
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ﬂow conditions used during resuspension. The use of lower
velocities forcell resuspension, albeit for a much greater numberof
passes, leads to nearly complete recovery for P4E6 and to small
losses (~4%) for OnyCap23.
The ease of cell pellet resuspension into single cell suspensions
was studied using an automated platform to allow multiple
studies under controlled conditions (Fig. 9). This necessitated
using lower RCF values and a narrower pipette diameter than for
resuspension studies reported above (Fig. 8). The tip velocities
and tip shear rates (~tip velocity/diameter) used were kept
within range of the previous resuspension studies. Cell pellets
were subjected to a set number of controlled aspiration/
resuspension cycles. P4E6 cells were almost totally resuspended
into a single cell suspension after only one controlled
resuspension cycle, yielding ~90% single cells from the total
cells originally pelleted. The release of OnyCap23 cells was more
gradual. The cells released for both cell lines were of cell integrity
consistently above ~95%. OnyCap23 cell aggregates require
considerably more mechanical manipulation to disperse into
single cell suspensions than equivalent P4E6 aggregates
indicating that cell-cell connections may be stronger within a
sedimented OnyCap23 population; perhaps the “stickier” of the
two cell lines. Higher rates of resuspension are achieved using
greater ﬂow rates. The translation of these observations on cell
resuspension to considerations of how large-scale operations
might be designed is discussed later.
Discussion
One key observation in this paper is that it is possible to achieve
high levels of cell recovery with membrane structure remaining
intact when operating at high relative centrifugal forces (ca
10000xg) for long spin times (30min). This allows high levels of
compaction of the cell pellet to be achieved which provides
advantages of easier decanting to remove supernatant, reduced
Figure 4. Recovery by centrifugation of P4E6 cells as a function of cell concentration, cell hold time prior to centrifugation, RCF and spin time. DoE relationship values are
reported as predicted percentage recovery of intact cells, REC (equation 1). The resultant model ﬁts incorporating terms relating to all three operating variables and their possible
combinations are of high signiﬁcance level (P¼0.02 and P¼0.03 for 1 10
6cells/mL and 2 10
6cells/mL, respectively. Temperature 21 C, medium CGM. The area to the left and
below the red dotted line (R<250xg and S<3min) represents data extrapolated from the model created. The effect of increased hold time is an approximately linear proportional
decrease in REC for the equivalent combinations of R and S (relationships not shown here).
1004 Biotechnology and Bioengineering, Vol. 112, No. 5, May, 2015carryoverofsolublecontaminantswiththecellsand,wherethecells
are to be used to prepare constructs, cell paste of suitable
concentration to mix with scaffold material.
The cell concentrations achieved for P4E6 were typically 1.1 to
1.3 fold higher than for OnyCap23; for example at RCF¼10000
xg,t i m e¼30min, 600 10
6cells/mLwas obtained for OnyCap23
compared with 800 10
6cells/mL for P4E6. The 1.2 fold larger
cell volume for OnyCap23 compared with P4E6 suggests the same
extent of dewatering for both cell suspensions based on residual
voidage in the sediment (the residual voidage appears to
approach zero but the size distribution data is not speciﬁc enough
to provide a deﬁnite value here; it would be expected that the cells
would be ﬂexible enough to pack down and ﬁll nearly all the
available space).
Asecondkeyobservationisthatcelldamageduringcentrifugation
is determined by the combined effects of the extent of compaction
achieved and the method of resuspension used. However, greater
compaction in itself does not appear to result in cell damage but
rather leads to increased hydrodynamic stress during resuspension.
A compacted cell pellet might be expected to have an apparent
viscosity, m, >0.02Nsm
 2 (Zoro et al., 2009). For a mean ﬂow
velocity, v, of 2.5ms
 1 in a 1.0mm id (d) pipette (Fig. 8), a
maximum wall stress, t, of ~300Nm
 2 might be estimated
(t¼8vm/d). This is of a similar level to the critical stress values of
275Nm
 2and235Nm
 2abovewhichdamageoccursforP4E6and
OnyCap23 cell lines, respectively (Acosta-Martinez et al., 2010) and
possibly explain the cell loss observed (Fig. 8). At 0.65m/s in a
1.0mmidtip,t¼70Nm
 2whichisprobablysufﬁcientlylowerthan
thecriticalshearstressvaluesforthetwocelllinestoresultinthelittle
to no loss of cells observed even for 100þ passes (Fig. 8). The
relativelylowcentrifugationspeedsusedforcellpelletpreparationfor
the resuspension studies reported in Fig. 9 will yield pellets of lower
initial viscosity than those used in Fig. 8 leading to the low levels of
cell loss noted despite the high tip velocities and shear rates used.
Figure 5. Recovery by centrifugationofOnyCap23 cells as afunction of cell concentration, cell hold time prior tocentrifugation, RCF and spintime. DoE relationshipvalues are
reported as predicted percentage recovery of intact cells, REC (equation 1). The resultant model ﬁts incorporating terms relating to all three operating variables and their possible
combinations are of high signiﬁcance level (P¼0.003 and P¼0.02 for 1 10
6cells/mL and 2 10
6cells/mL, respectively). Temperature 21 C, medium CGM. The area to the left and
below the red dotted line (R<250xg and S<3min) represents data extrapolated from the model created. The effect of increased hold time is an approximately linear proportional
decrease in REC for the equivalent combinations of R and S (relationships not shown here).
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feed of lower cell concentration (Figs. 4 and 5) using high degrees
of centrifugal compaction suggests that a ﬁxed number of cells
might be damaged in a resuspension process, this number
becoming increasingly signiﬁcant as the amount of cells present
decreases. The scaling rules determining resuspension of
different quantities of cells are yet to be determined. The studies
in this paper have focussed on avoiding regimes of possible
damage.
It has been suggested elsewhere (Papantoniou et al., 2011) that
cell damage during capillary ﬂow induced disruption of
embryoid bodies may be due to the sudden detachment of
neighbouring cells leading to wall damage in one of the detaching
cells. A similar mechanism might also be occurring during the
Figure 6. Surfacemarkeranalysis.ThenumberofmoleculesofsurfacemarkerpercellforeachofthesixsurfacemarkersinvestigatedforOnyCap23(A)andP4E6(B).Bothcell
lines were processed at 20000xg for 30min after 5min (&) and 120min (&) hold time, (n¼3, þ/  1 sd). Student’s t-test was conducted on the raw data, comparing processed to
control(&),(
*P<0.05,
**P<0.01,and
***P<0.001).Percentageintactcellvaluesarealsoindicatedforthecorrespondingcellpopulations.TheOnyvaxreleasecriteriathresholdfor
each surface marker is represented by the black lines. Cell marker properties: CD9—tetraspanin protein with role in the regulation and modulation of cell development, activation,
growth, aggregation, adhesion, and motility (Higginbottom et al., 2003; Ikeyama et al., 1993; Masellis-Smith & Shaw, 1994); CD44—linked to lymphocyte activation, recirculation and
homing, hematopoiesis, and tumor metastasis within prostate cell lines (Simon et al., 2009); CD59—protects human blood and vascular cells from injury and lysis (Zhao et al., 1998);
CD81—is involved in the immune response with increased expression on T cells during infection; CD147 or Collagenase Stimulatory Factor—co-ordination of cell adhesion with
proteolysis, cell communication and signal transduction (Guo etal., 1998; Muramatsu & Miyauchi, 2003; Nabeshima etal., 1991); MHC—major histocompatibility complex molecules
involved in the presentation of foreign antigens to the host immune system in order to elicit an immune response (Gruen & Weissman, 1997).
1006 Biotechnology and Bioengineering, Vol. 112, No. 5, May, 2015dispersion of the centrifuged cell pellet. The use of enzyme to
help disrupt matrices leading to cell-cell interaction was shown to
prevent cell damage during release from embryoid bodies
during capillary ﬂow. Similarly the use of enzyme digestion
prior to resuspension was found to reduce cell loss to negligible
levels (Fig. 8) although evidently this leaves the practical
dilemma of having to employ a separation technique to remove
the enzyme.
Onemethodofreducingcell-cellinteractioninthesedimentisby
changing the cell environment prior to processing. For example
surface proteins presented for the formation of cell-cell bonds
require the presence of Ca
2þ to facilitate the mechanisms by which
they cluster and present (Umbreit and Roseman, 1975). The
replacement of CGM withprotein-free Hanks balancedsaltsolution
(HBSS) (without Ca
2þ and Mg
2þ) led to a reduction in cell loss
(Fig. 8) although changes in cell elasticity and porosity as a
Figure 7. Normalized sizedistributions (withrespecttototal cellcounts)ofOnyCap23 and P4E6; (A)freshcontrol, (B)hold time (H)¼5min, centrifugationRCF(R)¼250xg,spin
time (S)¼3min, (C)H¼60min, R¼10000xg,S¼30min, (D)H¼120min, R¼20000xg,S¼30min. The mean cell diameter, number basis, and the % cell recovery, REC, are given as
insets. Temperature¼21 C.
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vulnerability to shear forces (Ramirez and Mutharasan, 1992).
Keeping hold times ofcells to minimum may also reduce the extent
of cell-cell interaction (clumping) and hence cell damage (Figs. 5
and 4).
Other cell quality indicators studied here included cell surface
markersandcellsize.Forbothofthesetheanalysisisofthecomplete
cell suspension, that is,mixes ofcellswithintact andwith disrupted
cell membrane. From size distribution studies of cells in suspended
form no evidence was found for signiﬁcant change in size of cells
surviving with the membrane intact (Fig. 7). Future studies will
examine the potential forcells to continue growing andthe resultant
morphology. The cell surface marker analysis (Fig. 6) generated
similardata aspreviously reported for shear studies of the same cell
lines (McCoy et al., 2009) where loss of cell membrane integrity
exceeds considerablyanychange inthe presence of surface markers.
Some possible trends are observed for a change in marker content
associated with a decrease in cell membrane integrity for: CD9 for
bothcelllines(butupforOnyCap23anddownforP4E6);CD147and
CD81 (both down); and CD59 (down for OnyCap23 only). Details of
the cell markers’ function are provided in Figure 6 legend.
The two cell types studied here exhibit different responses to
processing stresses and the trends observed here are the same as
reported elsewhere for different unit operation stress investigations
(Acosta-Martinezetal.,2010).MeasurementsoftheYoung’sModuli
of different prostate and prostate cancer tissue suggest P4E6 cells
Figure 8. Effectofdifferentresuspensionmethods.OnyCap23(A)andP4E6(B)celllineswereprocessedat20000xgfor30minafterholdtimesof(&)5minand(&)120min.For
theﬁrsttwodatasets,cellswerepreparedinCGM(Set1)orHBSS(Set2)andresuspendedmanuallyat2.5m/s.FortheremainingdatasetscellswererespectivelypreparedinCGM
and resuspended automatically at 0.65m/s, were treated with enzyme and resuspended at 2.5m/s or at 0.65m/s. Data presented as mean þ/  sd (n¼3). Signiﬁcant loss of
recovered intact cells compared with unprocessed cell samples were noted with P<0.05 (*), P<0.01 (**), P<0.001 (***).
1008 Biotechnology and Bioengineering, Vol. 112, No. 5, May, 2015have higher surface membrane deformability than cells similar to
the OnyCap23 cells; this is as a result of the state of health and
degree of metastasis of the P4E6 cells(Faria et al., 2008). This great
level of cell elasticity of P4E6 cells along with their smaller size
(Fig. 7) are possible contributory factors to the higher levels of
recovery of intact cells. It has also been observed that P4E6 cells
yield a more tightly packed pellet when centrifuged (Ramirez and
Mutharasan, 1990) which might lead to greater damage when
considering possible damage due to disruption of cell-cell contacts.
Howeverasindicatedaboveatthecentrifugationconditionsstudied
the dewatering levels achieved for the two cell lines were broadly
similar and the greater size of OnyCap23 cells would lead to greater
levels of cell-cell contact to be disrupted on resuspension. This
relates to the increased effect of hold time prior to centrifugation
especiallyasobservedathighercellconcentration(Figs.4Dand5D)
which might increase the extent of cell-cell interaction. A second
interestingobservationisthegreatersusceptibilityoftheOnyCap23
cell line at a lower start concentrationto damage by centrifugation/
resuspension. This might be related to protective effects often
observed at higher cell concentrations.
Processing Implications
The performance of a cell recovery process might be determined in
terms of the recovery of viable functional cells, the extent of
contaminant removal and in some instances the extent of cell
concentrationachieved. The use of high levels ofdewatering tohelp
aid contaminant removal might impact the yield of viable cells
unlesscareistakenoverthemethodofcellresuspension.Lowshear
stress multipass resuspension has to be achieved without increased
chance of contamination in what is an inherently non-enclosed
operation. Several alternatives to batch centrifugation exist for cell
recovery which may be used in a fully-enclosed mode. These
include: (i) the use of porousmembranes in crossﬂow mode under
controlled shear to prevent cell damage (Pattasseril et al., 2013;
Rowleyet al., 2012); (ii) the use of ﬁltration in dead end mode with
back ﬂush for recovery (Sowemimo-Cokeret al., 2009); (iii) the use
ofcontinuouscentrifugation(Johnsonetal.,1996;Kimetal.,2008);
(iv) the use of combined centrifugation and contraﬂow to band the
cells (James, 2011). In all cases the extent of cell concentration
achievedisgenerallylowsoastogiveacellsuspensionwhichﬂows.
Figure 9. EffectofvaryingthedeﬁnedcellresuspensionprotocolontherecoveryofcellsfromsedimentforOnyCap23(AandB)andP4E6(CandD).Theresultsarereportedas
(A and C) single cells in suspension as % total cells in pellet, and (B and D) the % cell integrity of the recovered single cells. Cells were transferred to a 96 well plate and pelleted at
either1500xgor2500xgfor5min.Upto25controlledaspirationcycleswerethenperformedusingaTecanautomatedplatformatvolumetricﬂowratesofeither600mL/sor900mL/s.
(2500xg,600mL/s(^);2500xg,900mL/s(&);1500xg,600mL/s(~).(600mL/spertransferofsuspension),withthepipettetiplocated4.57mm(i.e.,6 id)abovethepelletsurface,with
subsequent analysis of single cells released into suspension. Each trial conducted in triplicate; data presented as mean þ/  sd (n¼3).
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removal. There is evidence for greater cell loss in the enclosed
system due to increased potential for hold up of product in the
equipment, for example, for cross ﬂow ﬁltration (Rowley et al.,
2012). Each of the methods described are still under considerable
development with cross-ﬂow membrane techniques probably
providing currently the more accessible option for successful cell
harvesting if dead-end centrifugation is to be replaced on scale-up,
as scale down models exist for development work; for large scale
production processes, signiﬁcant development and application
work is occurring within an industrial context with contra-ﬂow
centrifugation operating in single-use containers.
The studies within this paper provide a method for determining
howdead-end batch centrifugation may be used toyield high levels
of dewatering (and hence contaminant removal) and also to retain
high levels of intact cell recovery by controlled resuspension. The
design of the resuspension process will be highly dependent on the
celltypeandhowthecellsinteractwitheachother(Fig.9).Acritical
design parameter is the maximum shear stress to which the cells
willbeexposedandevidentlyvariablespeed(forstirredsystems)or
ﬂow (for plunging jet systems) will allow control of shear stress as
the apparent viscosity of the pelleted cells is reduced as the
dispersion process proceeds. Application is still likely to require
operation in controlled environments, for example, using robotics
orcarefulmanualoperationbutthisstudydoespointwayfordesign
of integrated centrifugation, decanting and resuspension
operations.
An added beneﬁt of the formation of compact cell pastes is the
easier operation of the decanting stage without adventitious loss of
cells. Also, high dewatering levels leading to fewer wash stages
reduces the chance of contamination in this highly manual
operation. Finally, for process robustness it also appears that
substantial hold-times prior to centrifugation (up to 2h studied in
this paper) are possible without leading to signiﬁcant cell loss
provided the resuspension process is carefully controlled; this
provides a valuable contribution to achieving process robustness.
Future studies will report on the effect of centrifugation conditions
on a range of other aspects of cell quality which might affect their
use as a cell therapy. For example for the feed suspensions used in
thesestudies,theproportionsofcellswhichwereeitherearlyorlate
apoptoticor necrotic were in each case <5% of thetotalpopulation
(measured by detection of active caspases in combination with
membrane permeability using propidium iodide). Studies to be
reported (in preparation) demonstrate little to no increase in such
populations could be achieved by operation at high RCF (e.g.,
10000xg) provided care taken over the cell holding time before
centrifugation and the method of resuspension with this result
being easier to achieve with P4E6 cells compared with OnyCap23
cell lines.
Conclusions
TheuseofDesignofExperimentsmethodsprovidesausefulmeans
ofexploringthesynergisticeffectsofarangeofprocessingvariables
to help determine potential windows of operation for robust
preparation of cells. The extent of damage of cells during dead-end
batch centrifugation is determined primarily by a combination of
the extent of exposure to centrifugal forces (product of RCF and
spin time) and the method of cell pellet resuspension. This extent
of damage is increased by (a) the holding the cells prior to
centrifugation (for ~2h), (b) operation at lower cell concen-
tration in the feed, and (c) use of increased pipette tip velocities
during resuspension. The use of low pipette tip velocities reduces
this damage to negligible levels even over the large number
(>100) passages needed to effect complete resuspension. The
susceptibility to damage (i.e., loss of membrane integrity) is
affected by the choice of cell line. Damage as measured by change
in presence of cell surface markers is less marked than is
observed by loss of membrane integrity for both cell lines
studied.
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